MRCPsych CASC — 110 Interactive Clinical Assessment Stations

Prepare for the MRCPsych CASC with 110 interactive stations: candidate instructions, role-player briefs, step-by-step model dialogue, clinical tips and key takeaways across history-taking, risk, MSE, capacity and communication.

Chapter 1: Essential Skills & Scenarios (19 stations)

• 1. Assessment and Management of Alcohol-Related Cognitive Impairment with Driving Concerns (Communication)
• 2. Dialectical Behaviour Therapy (DBT) Assessment and Engagement in EUPD (Psychotherapy)
• 3. Non-Medication Treatment Options for Depression (Communication)
• 4. Treatment Discussion for Recurrent Depressive Disorder (Psychopharmacology)
• 5. Cerebellar Examination in Alcohol-Related Ataxia (Physical Examination)
• 6. CBTp for First-Episode Psychosis (Psychotherapy)
• 7. Discharge Planning for Violent Elderly Patient (Management)
• 8. Risk Assessment & Management of Paranoia in a Prisoner (Forensic)
• 9. Mental State Examination for Thought & Perception Disturbance (MSE)
• 10. Mental State Examination for Postnatal Psychopathology (MSE)
• 11. MSE - Psychotic Depression with Cotard's Delusion (MSE)
• 12. Mental State Examination for Hypomania (MSE)
• 13. Safeguarding Concerns in Learning Disability (CAMHS)
• 14. Collateral History - Depression/Dementia (History Taking)
• 15. Collateral History - Suspected ADHD (CAMHS)
• 16. Cognitive Exam - Global Atrophy with Frontal Signs (Cognitive Assessment)
• 17. Cognitive Exam - Full MMSE Assessment (Cognitive Assessment)
• 18. Cognitive Exam - Parietal Lobe Assessment (Cognitive Assessment)
• 19. Cognitive Exam - Temporal Lobe Assessment (Cognitive Assessment)

Chapter 2: Advanced Clinical Stations (20 stations)

• 1. Learning Disability and Human Rights – Sterilisation Ethics (LD/Ethics)
• 2. Suicide Safety Risk Planning (Risk Assessment)
• 3. Management of Relapse of Schizophrenia in Community (Management)
• 4. Schizophrenia + Quetiapine + Bradycardia & QTc Prolongation (Psychopharmacology)
• 5. Sodium Valproate and Pregnancy (Psychopharmacology)
• 6. Systematic Desensitisation for Agoraphobia (Psychotherapy)
• 7. Perimenopausal Symptoms in Bipolar Disorder (History Taking)
• 8. Physical Examination of EPSE (Physical Examination)
• 9. Forensic Risk Assessment – Fire-Setting and EUPD Traits in a Young Adult (Forensic)
• 10. MSE – Acute Psychosis/Mania (Drug-Induced) (MSE)
• 11. Drug-Induced Hypomania in Parkinson's Disease (MSE)
• 12. Autism Spectrum Disorder – Developmental History (CAMHS)
• 13. Alcohol Dependence, Anxiety, Elevated LFTs, Still Driving (Substance Misuse)
• 14. Financial Capacity Assessment (MCA/Capacity)
• 15. MSE for OCD (MSE)
• 16. CMHT Outpatient MSE – Schizophrenia Follow-up (MSE)
• 17. Capacity to Refuse Social Care — Elderly Patient with Dementia (MCA/Capacity)
• 18. Capacity to Refuse Medical Procedure (OGD) — Patient with Psychosis (MCA/Capacity)
• 19. Financial Capacity Assessment — Grandiose Delusions in an Elderly Patient (MCA/Capacity)
• 20. Capacity to Refuse Surgical Wound Closure — Prisoner with EUPD (MCA/Capacity)

Chapter 3: Clinical Scenarios & Communication (71 stations)

• 1. Assessing Suitability for IPT (Interpersonal Psychotherapy) (Psychotherapy)
• 2. Antenatal Mental Health Review — Quetiapine and Gestational Diabetes (Psychopharmacology)
• 3. Clozapine Discussion in Treatment-Resistant Schizophrenia (Psychopharmacology)
• 4. Informing and Reassuring an Angry Relative About a Schizophrenia Diagnosis (Communication)
• 5. Exploring Therapy Termination — Patient Wanting to Leave Psychotherapy Following Therapist's Leave of Absence (Psychotherapy)
• 6. Perinatal Risk Assessment — Domestic Abuse and Disrupted Family Relationships (Risk Assessment)
• 7. Collateral History from Spouse — Vascular Dementia (Communication)
• 8. Reassuring an Anxious Patient with Normal Cognitive Testing — Memory Concerns Without Dementia (Communication)
• 9. Acute Psychosis and DVLA — Addressing Driving Concerns After a Psychotic Episode (Communication)
• 10. Hyperprolactinaemia on Olanzapine — Focused History, Explaining Results, and Holistic Management (Psychopharmacology)
• 11. Postpartum Psychosis — Assessing Nature and Severity of Symptoms and Risk in a Mother Who Believes Her Baby Is Possessed (Risk Assessment)
• 12. Lewy Body Dementia — Devising a Management Plan with the Grandson Following New Behavioural Changes (Communication)
• 13. Dementia and Depression in Down Syndrome — Collateral History from Mother and Arriving at an Explanation (Clinical Assessment)
• 14. Self-Harm History and Risk Assessment — First-Time Wrist Cutting in a University Student Under Academic and Financial Stress (Risk Assessment)
• 15. Conversion Disorder (Functional Neurological Symptom Disorder) — History of Presenting Complaint and Social History (Clinical Assessment)
• 16. Autism vs Schizophrenia — MSE, Exploration of Behavioural Change, and Differentiating ASD Traits from Psychotic Features (Mental State Examination)
• 17. Schizophrenia and Employment Loss — Explore Changes After Employer Conflict, Risk Assessment, and Management Plan (Risk Assessment)
• 18. Alzheimer's Disease — Genetic Risk Counselling for the Adult Child of a Newly Diagnosed Patient (Communication)
• 19. Adult ADHD — Explaining Diagnosis and Discussing a Comprehensive Management Plan (Communication)
• 20. Mental Capacity Assessment — Starting Sertraline in a Depressed Man with Learning Disability (Clinical Assessment)
• 21. SSRI Sexual Dysfunction — Explore the Patient's Reasons for Stopping Medication and Assess Aetiological Factors (Communication)
• 22. Anorexia Nervosa — Discussing Prognosis with a Relative: Favourable and Unfavourable Prognostic Factors Including Personality Traits (Communication)
• 23. Schizophrenia — Discharge Planning Discussion with the Mother of a Patient Who Assaulted Her: Psychoeducation, Expectations, and Safety Plan (Communication)
• 24. Elderly Depressed Patient with Alcohol Use — History-Taking to Explore Reasons for Weight Loss (Clinical Assessment)
• 25. Schizophrenia in a Forensic Unit — Mental State Examination and Risk Assessment of a Patient with Paranoid Delusions and Stated Intent to Harm (Mental State Examination)
• 26. Lewy Body Dementia — Neurological Examination Focused on Parkinsonism (Clinical Assessment)
• 27. Family Dynamics and Highly Expressed Emotion — History-Taking with a Carer and Introduction to Family Intervention (Communication)
• 28. Mental State Examination — Acute Psychosis with Persecutory Delusions and Auditory Hallucinations (The Postman) (Mental State Examination)
• 29. Mental State Examination — Acute Mania with Grandiose Delusions (Madonna is My Sister) (Mental State Examination)
• 30. Somatic Symptom Disorder with Predominant Pain — History-Taking (Do Not Discuss Diagnosis) (Clinical Assessment)
• 31. Mental State Examination — Delusional Disorder (Government Chip Implanted via "The Tube Test"; Significance of 666) (Mental State Examination)
• 32. Lewy Body Dementia with Learning Disability — Explaining the DATscan Result and Biopsychosocial Management to the Patient's Sister (Communication)
• 33. First Episode Psychosis — Biopsychosocial Management Discussion with the Patient's Mother (Olanzapine Side Effects, High Expressed Emotion, and Social Losses) (Communication)
• 34. Forensic Risk Assessment — Indecent Exposure (Exhibitionistic Disorder) (Risk Assessment)
• 35. Delirium Superimposed on Lewy Body Dementia — Informant History from Nursing Staff, Coming to the Diagnosis (UTI, Bereavement, Fall, Aggression) (Clinical Assessment)
• 36. Opioid Use — Comprehensive Drug History and Associated Risk Assessment (Clinical Assessment)
• 37. Alcohol History — Social Impact Assessment and Insight/Motivation (Marital Crisis, Wife's Ultimatum) (Clinical Assessment)
• 38. PTSD History-Taking — Ex-Combat Veteran, Afghanistan (IED Incident, Survivor Guilt, Moral Injury) (Clinical Assessment)
• 39. Panic Attacks and Social Avoidance — History-Taking and Diagnosis Delivery (Best Man Speech, Wedding in Six Weeks) (Clinical Assessment)
• 40. Paedophilic Disorder — Risk Assessment (Voluntary Disclosure to Police; Babysitting Incident; Pre-Contact Presentation) (Risk Assessment)
• 41. Heroin Dependence — History-Taking and Risk Assessment (IV Use, Three Overdoses, HCV, Pregnant Partner, Harm Reduction) (Clinical Assessment)
• 42. Displacement Reaction — Occupational Agitation Secondary to Suspected Marital Infidelity (Communication)
• 43. Neuroleptic Malignant Syndrome — Explaining the Diagnosis and Management Plan to a Patient's Father (Communication)
• 44. Hypochondriasis — Explaining the Diagnosis and Treatment to a Patient's Girlfriend (Communication)
• 45. Post-MI Depression and Cardiac Rehabilitation — Teaching a Medical Student (Communication)
• 46. Alcohol Withdrawal Delirium — Liaison Discussion with an Orthopaedic Nurse (Communication)
• 47. Anorexia Nervosa — Explaining the Diagnosis and Treatment to a Patient's Mother (Communication)
• 48. Puerperal Psychosis Prophylaxis — Pre-Birth Counselling at 36 Weeks (Communication)
• 49. Medically Unexplained Cardiac Symptoms — History, Vulnerability, and Allaying Anxiety (Clinical Assessment)
• 50. CAMHS Developmental History — Thomas, Age 8, with Aggressive Behaviour (Clinical Assessment)
• 51. Mental State Examination — Mr Miller, 35, Referred with Possible Psychotic Symptoms (Mental State Examination)
• 52. Dissociative Stupor — Brief History from Mother and Explanation of Diagnosis (Communication)
• 53. Exploring Delusions — Primary vs Secondary, and Risk Assessment: Mrs Margaret Hughes, 60 (Mental State Examination)
• 54. Clozapine, Discharge Concerns, and Safeguarding — Talking to Daniel Carter's Angry Mother (Communication)
• 55. Delusions of Guilt in Late Life — History from Mrs Dorothy Hawkins, 73 (History Taking)
• 56. Suicide Risk Assessment After Overdose — Ms Sophie Ahmed, 22, Third ED Presentation in 10 Days (Risk Assessment)
• 57. Psychosocial Treatments for Negative Symptoms and Depression — Miss Brown, 31 (Management Planning)
• 58. Post-Bereavement History and Formulation — Mrs. Margaret Brown, 53 (History Taking and Formulation)
• 59. Weight Gain — Psychosocial History and Motivation to Change (History Taking)
• 60. Lithium Augmentation — Explanation and Discussion (Psychopharmacology)
• 61. Electroconvulsive Therapy — Explanation and Discussion (Psychopharmacology)
• 62. Bipolar Affective Disorder — Diagnosis and Management Plan (Management Planning)
• 63. Mental Capacity Assessment and Best Interests — Collateral: Support Worker (Mental Capacity)
• 64. Morbid Jealousy — Diagnosis, Risk, and Management — Collateral: Partner (Risk Assessment)
• 65. Paracetamol Overdose — History, Risk Assessment, and Discharge Decision — Aisha Khan, 16 (Risk Assessment)
• 66. Clozapine-Induced Metabolic Syndrome — Explaining Results and Management Plan (Psychopharmacology)
• 67. Erotomania — History Taking and Dangerousness Assessment (Risk Assessment)
• 68. Refeeding Syndrome in Anorexia Nervosa — Collateral: CAMHS CPN (Communication)
• 69. Acute Mania on PICU — Discussing Treatment Options with Nurse in Charge (Management Planning)
• 70. Seclusion Review of a Dehydrated Patient — Handover from Nurse O'Brien (Management Planning)
• 71. Olanzapine-Induced Weight Gain — Discussing Weight Management with a Patient (Psychopharmacology)

Also see the CASC Success Guide eBook and the guide to the seven CASC station types.